We describe a novel, biologically distinct type of CNS embryonal tumor—ET, PLAGL—that is presumably driven by amplification and subsequent overexpression of PLAGL1 or PLAGL2, the only recurrent molecular event detected in these tumors. This evidence concerns the gene PLAGL1 and neoplasm.